Christopher Thomas Primiani, MD
Neurology · Philadelphia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Temple Faculty Practice Plan Inc · 1,325 clinicians in this group
Hospitals listed: Temple University Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Primiani’s office at (215) 707-3008 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Temple University HospitalPhiladelphia, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Temple University Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.592, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.661, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.389, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.257, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 4.3 (3.5 to 5.3) · 1,422 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Temple University Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.592 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.661 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.389 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.257 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (3.5 to 5.3) · 1,422 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.94 (1.03 to 2.85) · 1,604 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.75 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 194.9 (148.67 to 241.13) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 480 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 337 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 488 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,885 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 9,057 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.04 to 0.4) · 9,949 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.65 (1.89 to 5.42) · 1,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.77 (0.48 to 3.07) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (1.22 to 3.88) · 1,671 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.48 (5.54 to 15.42) · 808 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.55 (1.65 to 7.44) · 856 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.1 to 2.94) · 358 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.09 to 0.95) · 7,676 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 195 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.78 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.722 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 294 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 1,587 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18.4 · 124 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.4 · 600 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.6 · 353 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 873 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (8.9 to 11.6) · 1,422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 199 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 804 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.6 to 16.5) · 713 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 638 cases | No different | Jan 2024 – Dec 2024 |
What patients said (721 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$1,971
Medicare paid this office $1,971 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 61 · 85 and older 0% · Health risk score 2.20. Above the middle of the specialty; the typical neurology clinician is at 1.61.
The office billed $9,822, Medicare allowed $2,640 and paid $1,971; for 16 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$201,044
Pharmacies billed $201,044 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 74) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
54 generic and 20 brand-name prescriptions · $201,044 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lamotrigine | 16 | $133 | $8 |
Year by year
| 2024 | 74 | 23 | 0% (0) | 27% | $201,044 |
| 2023 | 57 | 13 | 0% (0) | None | $2,191 |
| 2022 | 69 | 23 | 0% (0) | None | $5,136 |
| 2021 | 75 | 17 | 0% (0) | 16% | $9,522 |
| 2020 | 54 | 19 | 0% (0) | 28% | $7,582 |
| 2019 | 20 | None | None | None | $636 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Levetiracetam | 14 | $282 | $20 |
2022: 1 drug
| Levetiracetam | 12 | $310 | $26 |
Money from drug and device companies
$3,481 in 2025
| 2025 | 4 | 6 | $3,000 | $3,481 |
| 2024 | 3 | 7 | None | $2,553 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ceribell | Pocket Eeg Device | $3,000 | 1 payment
|
| SK Life Science | None | $227 | 3 payments
|
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $136 | 1 payment
|
| Jazz Pharmaceuticals | Epidiolex | $118 | 1 payment
|
See all 6 published payments
| SK Life Science | Meals · 2025-12-06 | None | $118 |
| Ceribell | Consulting · 2025-08-22 | Pocket Eeg Device | $3,000 |
| LivaNova USA | Meals · 2025-04-29 | Vns Therapy Sentiva Model 1000 Generator | $136 |
| Jazz Pharmaceuticals | Meals · 2025-04-09 | Epidiolex | $118 |
| SK Life Science | Meals · 2025-04-09 | None | $39 |
| SK Life Science | Meals · 2025-04-06 | None | $70 |
See earlier years (2024)
2024: $2,553
| Neuropace | Rns Neurostimulator Kit | $1,428 | 4 payments
|
| Ceribell | Pocket Eeg Device | $1,000 | 2 payments
|
| SK Life Science | Xcopri | $125 | 1 payment
|
Professional record
- NPI
- 1043877327
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X); Federal specialty code 2084E0001X (2084E0001X)
- Mailing address
- 3500 N Broad St Rm 1a, Philadelphia, PA, 19140
- NPI first listed
- 2019-05-22
- NPI last updated
- 2025-10-01
- NPI record certified
- 2025-10-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5200 Eastern Ave Rm 342, Baltimore, MD, 21224 · 300 Pasteur Dr, Palo Alto, CA, 94304